• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    1.19 Up 0.01(0.85%) Mar 27, 4:00PM EDT
    |After Hours : 1.20 Up 0.01 (0.84%) Mar 27, 5:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 3,769   1,105   1,290   1,434  
    Cost of Revenue1,416  337  766  421  
    Gross Profit 2,353   768   524   1,013  
    Operating Expenses
    Research Development2,999  3,140  4,674  4,292  
    Selling General and Administrative3,671  5,516  6,535  6,268  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,317) (7,888) (10,685) (9,547)
    Income from Continuing Operations
    Total Other Income/Expenses Net(354)(236)(58)88  
    Earnings Before Interest And Taxes(4,671)(8,124)(10,743)(9,459)
    Interest Expense1,085  1,260  1,085  941  
    Income Before Tax(5,756)(9,384)(11,828)(10,400)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(5,756)(9,384)(11,828)(10,400)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (5,756) (9,384) (11,828) (10,400)
    Preferred Stock And Other Adjustments(1,169) -   -   -  
    Net Income Applicable To Common Shares (6,925) (9,384) (11,828) (10,400)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.